Literature DB >> 26162574

Desmoid-type fibromatosis.

S Otero1, E C Moskovic2, D C Strauss2, C Benson2, A B Miah2, K Thway2, C Messiou2.   

Abstract

Desmoid-type fibromatosis is a rare, locally infiltrative, mesenchymal neoplasm that is associated with high rates of local recurrence but lacks the potential to metastasise. The disease affects younger individuals, with a peak age of 30 years, and is the most common cause of an anterior abdominal wall mass in young women of childbearing age. It may, however, involve nearly every body part, including the extremities, head and neck, trunk, and abdominal cavity; as such, desmoid-type fibromatosis may present to a range of general and subspecialty radiologists. These rare tumours have a widely variable clinical presentation and unpredictable natural history, hence input from a soft-tissue tumour centre is recommended, although much of the imaging may be performed at the patient's local hospital. The consensus for treatment has changed over the past decade, with most centres moving away from primary radical surgery towards a front-line 'watch-and-wait' policy. Therefore, imaging has an increasingly important role to play in both the diagnosis and follow-up of these patients. This review will discuss the typical imaging characteristics of these lesions and suggest diagnostic and follow-up magnetic resonance imaging protocols, with details of suitable sequences and scanning intervals.
Copyright © 2015 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26162574     DOI: 10.1016/j.crad.2015.04.015

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  17 in total

1.  Pseudoaneurysm within a desmoid tumor in an extremity: report of 2 cases.

Authors:  Niamh M Long; Mrinal M Gounder; Aimee M Crago; Alexander J Chou; David M Panicek
Journal:  Skeletal Radiol       Date:  2021-03-16       Impact factor: 2.199

2.  Peutz-Jeghers syndrome with mesenteric fibromatosis: A case report and review of literature.

Authors:  Huai-Jie Cai; Han Wang; Nan Cao; Wei Wang; Xi-Xi Sun; Bin Huang
Journal:  World J Clin Cases       Date:  2020-02-06       Impact factor: 1.337

3.  Desmoid-Type Fibromatosis-Clinical Study of an Uncommon Disease.

Authors:  Sreekanth S Kumar; K Rajeevan; E Devarajan
Journal:  Indian J Surg Oncol       Date:  2019-11-04

4.  A rare case of infantile desmoid-type fibromatosis on the thigh.

Authors:  Shuaihantian Luo; Guilin Tang; Guiying Zhang
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 [SEASON]       Impact factor: 2.545

Review 5.  The Role of Radiation Therapy for Symptomatic Desmoid Tumors.

Authors:  Wen Shen Looi; Daniel J Indelicato; Michael S Rutenberg
Journal:  Curr Treat Options Oncol       Date:  2021-03-01

6.  Local recurrence of sporadic mesenteric fibromatosis following radical surgery attacking the proximal jejunum.

Authors:  Selçuk Gülmez; Ebubekir Gündeş; Aziz Serkan Senger; Orhan Uzun; Ulaş Aday; Hüseyin Çiyiltepe; Durmuş Ali Çetin; Emre Bozdağ; Kamuran Cumhur Değer; Erdal Polat
Journal:  Prz Gastroenterol       Date:  2017-09-30

7.  Aggressive fibromatosis response to tamoxifen: lack of correlation between MRI and symptomatic response.

Authors:  M Libertini; I Mitra; W T A van der Graaf; A B Miah; I Judson; R L Jones; K Thomas; E Moskovic; Z Szucs; C Benson; C Messiou
Journal:  Clin Sarcoma Res       Date:  2018-05-14

Review 8.  Can ovaries be preserved after an ovarian arteriovenous disconnection? One case report and a review of surgical treatment using Da Vinci robots for aggressive ovarian fibromatosis.

Authors:  Jun Ying; Jiawen Feng; Jinghui Hu; Shuo Wang; Peilin Han; Yujie Huang; Wei Zhao; Jianhua Qian
Journal:  J Ovarian Res       Date:  2019-06-07       Impact factor: 4.234

Review 9.  An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG).

Authors:  B Kasper; C Baumgarten; J Garcia; S Bonvalot; R Haas; F Haller; P Hohenberger; N Penel; C Messiou; W T van der Graaf; A Gronchi
Journal:  Ann Oncol       Date:  2017-10-01       Impact factor: 32.976

10.  Effective treatment of aggressive fibromatosis with celecoxib guided by genetic testing.

Authors:  Shanshan Yang; Xufu Wang; Haiping Jiang; Yongjie Wang; Zhuokun Li; Haijun Lu
Journal:  Cancer Biol Ther       Date:  2017-09-07       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.